Pneumococcal 24-Valent Conjugate Vaccine（Jiangsu Kunli）

24价肺炎球菌多糖结合疫苗（江苏坤力）

Report date: 2022/02/21 20:00:30

Base Information

Drug NamePneumococcal 24-Valent Conjugate Vaccine（Jiangsu Kunli）
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSepsisPneumonia, PneumococcalPneumococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Kunli Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kunli Biopharmaceutical Co LtdJiangsu Kunli Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSepsisPneumonia, PneumococcalPneumococcal Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A